ESR1 and cancer: Using preclinical metastatic ER+ in vivo and ex vivo models, this study shows that activation of GR by the synthetic glucocorticoid Dexamethasone (Dex), reduces liver metastases and prolongs survival of the animals by inhibiting cell intrinsic mechanisms essential for cancer cell growth in the metastatic niche.